Showing results (61-70 of 345) with videos related to

Sort By:
Pageof 35
Molecular and Cellular Endocrinology|May 5, 2010
Pituitary tumours: the sst/D2 receptors as molecular targetsLeo J Hofland, Richard A Feelders, Wouter W de Herder, et al.
Endocrine-Related Cancer|September 1, 2012
New developments in the medical treatment of Cushing's syndromeR van der Pas, W W de Herder, L J Hofland, et al.
Endocrinology|January 1, 1994
Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cellsL J Hofland, P M van Koetsveld, M Waaijers, et al.
Endocrine-Related Cancer|December 14, 2017
Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrumAnela Blažević, Johannes Hofland, Leo J Hofland, et al.
Drugs|June 6, 2013
Recent developments in drug therapy for Cushing's diseaseRob van der Pas, Wouter W de Herder, Leo J Hofland, et al.
Pancreas|May 4, 2006
The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial monolayersWilhelmina M U van Grevenstein, Leo J Hofland, Johannes Jeekel, et al.
The Journal of Investigative Dermatology|July 20, 2007
Effects of topically applied acitretin in reconstructed human epidermis and the rhino mouseEdward Hsia, Michael J Johnston, Robert J Houlden, et al.
Molecular and Cellular Endocrinology|November 1, 1987
Weak estrogenic activity of phenol red in the culture medium: its role in the study of the regulation of prolactin release in vitroL J Hofland, P van Koetsveld, J W Koper, et al.
Annales D'Endocrinologie|January 4, 2015
Medical therapies in pituitary adenomas: Current rationale for the use and future perspectivesThomas Cuny, Anne Barlier, Richard Feelders, et al.
European Journal of Endocrinology|April 7, 2007
Novel insights in dopamine receptor physiologyRosario Pivonello, Diego Ferone, Gaetano Lombardi, et al.
Pageof 35